We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights: Johnson & Johnson, Visa, Verizon, Alphabet and Altria
Read MoreHide Full Article
For Immediate Release
Chicago, IL –September 26, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Johnson & Johnson (JNJ - Free Report) , Visa (V - Free Report) , Verizon (VZ - Free Report) , Alphabet (GOOGL - Free Report) and Altria (MO - Free Report) .
Here are highlights from Tuesday’s Analyst Blog:
Top Research Reports for Johnson & Johnson, Visa & Verizon
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson, Visa and Verizon. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Johnson & Johnson’s shares have underperformed the Zacks Large Cap Pharmaceuticals industry year to date, gaining +0.6% vs. +6.7%. However, J&J’s sales growth has accelerated since second half of 2017 backed by higher sales in the Pharmaceutical unit and improving performance in Medical Devices unit. J&J has already raised its full-year organic sales growth expectations twice this year.
Though quite a few key products in J&J’s portfolio like Remicade and Concerta are facing generic competition, the Zacks analyst thinks new products in all segments, successful label expansion of cancer drugs like Imbruvica and Darzalex and contribution from recent acquisitions will continue to drive top-line growth.
J&J also enjoys a robust multi-year pipeline of new drugs and line extensions. Meanwhile, share buybacks and restructuring initiatives should provide bottom-line support. Headwinds like generics, pricing pressure, sluggish growth in the Consumer unit and soft global market conditions remain.
Shares of Buy-ranked Visa have outperformed the Zacks Financial Transaction Services industry over the past year (+44.9% vs. +38.7%). The Zacks analyst thinks the company is witnessing growth in payments volume, cross-border volume and processed transactions owing to a strong economy and positive consumer sentiment driving higher spending.
Numerous strategic acquisitions and alliances, technology upgrades and effective marketing have paved the way for long-term growth and consistent revenue rise. Visa is well poised to gain from the growing electronic payment processing and a strong international business.
Given solid operational performance, management expects fiscal 2018 operating EPS to grow in low-30s on low double digits revenue growth. A solid balance sheet ensures effective capital deployment. Nevertheless, high client incentives might put pressure on revenues.
Buy-ranked Verizon’s shares have gained +8.1% over the past year, outperforming the Zacks Wireless National industry’s loss of -2.7% during the same period. Verizon expects healthy improvement in margins on the back of strong FiOS network and strategic services in the Wireline business.
The company plans to launch next-generation 5G wireless residential broadband services in three to five U.S. markets in 2018. The Zacks analyst thinks focus on online content delivery, mobile video and online advertising will drive growth. Aggressive expansion in fiber optics network also augurs well.
Verizon has already started upgrading the aging copper network infrastructure of Boston and Sacramento with fiber and wireless network to support high-end mobile and wireline services for smart city, residential and business applications. However, the company continues to struggle in a highly competitive and saturated wireless market, where spectrum crunch has become a major issue, reducing its profitability to some extent.
Other noteworthy reports we are featuring today include Alphabet and Altria.
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights: Johnson & Johnson, Visa, Verizon, Alphabet and Altria
For Immediate Release
Chicago, IL –September 26, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Johnson & Johnson (JNJ - Free Report) , Visa (V - Free Report) , Verizon (VZ - Free Report) , Alphabet (GOOGL - Free Report) and Altria (MO - Free Report) .
Here are highlights from Tuesday’s Analyst Blog:
Top Research Reports for Johnson & Johnson, Visa & Verizon
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson, Visa and Verizon. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Johnson & Johnson’s shares have underperformed the Zacks Large Cap Pharmaceuticals industry year to date, gaining +0.6% vs. +6.7%. However, J&J’s sales growth has accelerated since second half of 2017 backed by higher sales in the Pharmaceutical unit and improving performance in Medical Devices unit. J&J has already raised its full-year organic sales growth expectations twice this year.
Though quite a few key products in J&J’s portfolio like Remicade and Concerta are facing generic competition, the Zacks analyst thinks new products in all segments, successful label expansion of cancer drugs like Imbruvica and Darzalex and contribution from recent acquisitions will continue to drive top-line growth.
J&J also enjoys a robust multi-year pipeline of new drugs and line extensions. Meanwhile, share buybacks and restructuring initiatives should provide bottom-line support. Headwinds like generics, pricing pressure, sluggish growth in the Consumer unit and soft global market conditions remain.
Shares of Buy-ranked Visa have outperformed the Zacks Financial Transaction Services industry over the past year (+44.9% vs. +38.7%). The Zacks analyst thinks the company is witnessing growth in payments volume, cross-border volume and processed transactions owing to a strong economy and positive consumer sentiment driving higher spending.
Numerous strategic acquisitions and alliances, technology upgrades and effective marketing have paved the way for long-term growth and consistent revenue rise. Visa is well poised to gain from the growing electronic payment processing and a strong international business.
Given solid operational performance, management expects fiscal 2018 operating EPS to grow in low-30s on low double digits revenue growth. A solid balance sheet ensures effective capital deployment. Nevertheless, high client incentives might put pressure on revenues.
Buy-ranked Verizon’s shares have gained +8.1% over the past year, outperforming the Zacks Wireless National industry’s loss of -2.7% during the same period. Verizon expects healthy improvement in margins on the back of strong FiOS network and strategic services in the Wireline business.
The company plans to launch next-generation 5G wireless residential broadband services in three to five U.S. markets in 2018. The Zacks analyst thinks focus on online content delivery, mobile video and online advertising will drive growth. Aggressive expansion in fiber optics network also augurs well.
Verizon has already started upgrading the aging copper network infrastructure of Boston and Sacramento with fiber and wireless network to support high-end mobile and wireline services for smart city, residential and business applications. However, the company continues to struggle in a highly competitive and saturated wireless market, where spectrum crunch has become a major issue, reducing its profitability to some extent.
Other noteworthy reports we are featuring today include Alphabet and Altria.
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Click here for the 6 trades >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
http://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.